Member Info for The.Italian

morning bignose.you're welcome.see we had a big 10k @0.081 just before close,to move s/p up.doubt that will convince anyone to buy into the rights,but who knows.

re your 3.59 post im not sure where the figure of 2399421215 comes from. the 26th sept circular states there were 2400347881 shares in issue at that date.it doesn't look as though any options have been exercised in the interim (see the monthly return of todays date).the 2468728881 is the maximum figure which could have been issued if all the possible options outstanding had been exercised,but i think we can now regard this as a purely academic figure.not totally sure why the aastock site give the issued capital of 4,801m but i assume it is because all the possible rights shares which could be taken up in principle have to be issued in anticipation, but if some actually don't get taken up as per my last post, then they simply get cancelled.not 100% sure here but nothing else really makes sense imo. again apologies if im telling you something you are already fully aware of, but i agree it's all a bit confusing. but then its erp so what should we expect! lol

bignose replying to you query in your 3.47 post i think you will find the answer on page 39 of the 26th sept announcement. the first table shows in the end column what would happen if no qualifying shareholders took up their rights and none of the unsubscribed rights could be placed with placees. in that event the shares actually taken up would be those guaranteed by the underwriter(galloway) namely1,569,711,046 and those subject to the irrevocable undertaking by mellon namely 506,680,329. that would leave a balance from the total rights to be issued of 2,400,347,881 of 323,956,506. so in those circumstances approximately 323m shares would not be issued (perhaps more accurately they would be cancelled as i think they may technically already have been issued ,hence the reference on aastocks to the new issued share capital ofapprox4,801m).hope this makes sense and apologies if you are already clear on this.

morning bignose. interesting post re yooma. i do keep an eye on the Seed board from time to time, just out of interest and it seems yooma has had a fairly active and slightly chequered history,including the acquisition of the gloriously named Big Swig drinks company. it was suspended very briefly for failure to file accounts,but this seems to have been just a genuine administrative difficulty and it was restored very quickly after filing them. it's been very acquisitive it seems and as the CBD space is very crowded,it may turn out to be a case of survival of the fittest. only time will tell whether we escaped its net or it escaped ours (although atm it looks like the former.)

i will have a look later at the points you raise re the rights issue,although i doubt i will be able to shed any meaningful light on matters.

incidentally ,i see they stuck in the big 10k again just before close to keep us flat.lol!

ripley, just to clarify, i would certainly seriously consider taking up the rights if i were able to do so, provided (a) the price was at a reasonable discount to the current s/p and (b) the contents of the prospectus gives support to the future prospects vis a vis the chinese and FDA approval processes, which are clearly key to a successful outcome.

yes ripley,i have been a holder since dec 2013(bignose even longer).for completeness sake,i sold out entirely when the s/p spiked to 0.6hkd or thereabouts, but bought back in with my original stake about 2 weeks later, as i felt the potential was still significant.the profit i made on my original investment means the in strict arithmetical terms i am not as badly down as i would have been had i not taken profits,but i am still well down.i intend to stick it out(despite getting on in years)to see what happens when/if we get chinese and fda approval. im sure you will make up your own mind, of course, and this is not advice just outlining my approach.i live in the uk and probably wouldn't be able to take up the rights,but obviously as things stand the current s/p is below the rights price,so i think you expectation of a poor take up is probably right.what im personally most interested in at the moment is the prospectus which will be issued soon re the rights issue.it's goingto be interesting to see if it clarifies some on the concerns we have about recent developments(singapore approval and approval of new EU manufacturer)which we know have happened but which have not been announced to the market,also news on china and fda progress would be welcome.

yes.i always thought that it was totally inappropriate not to have reserved a contingency in the accounts(which i don't think they ever did)when dealing with a speculative and uncertain issue such as an alleged tax liability. you simply can't,or shouldn't,place 100% reliance on what your tax advisors tell you,particularly when the aussie tax authorities were obviously pretty relentless in pursuing matters.water under the bridge of course,but fairly fetid water im afraid.

afternoon bignose.nothing to add to you excellent summary,apart from endorsing how depressing it is to see the catalogue of ineptitude summarised in this way. actually just thought to add that the position would be even worse if it were not for the(purely fortuitous imo) beneficial effect of holding and disposing of the legacy investment in develop global (formerly venturex).

you're welcome. when i saw the double red dots i did get my hopes up for a moment, but realistically im not expecting any substantive news until latter part of Q1 23.the problem as always though,is if you are not in it's always too late when the news drops.no advice intended of course.

purely administrative,just confirming the current issued share capital and the balance of unissued/unallocated shares under the various option schemes .nothing of interest im afraid.

morning bignose.yes it's all very odd how nothing has been announced,but we are edging closer to the issue of the prospectus,which presumably will have to clarify some of these issues(or maybe not!). ripley here is the timetable in the announcement of 31st october.shares have gone ex rights today,which may have something to do with what you are seeing in your account http://www.endurancerp.com/ICMServlet/download/13-2646-4296/ew_00575Ann-31102022%20(b).pdf

https://www.punchline-gloucester.com/articles/aanews/video-gloucestershire-business-versarien-plc-gearing-up-for-the-graphene-revolution just out o interest. courtesy of jointer on advfn

afternoon bignose. hope you are wrong,but suspect you are right. the news lockdown continues,so looks like we will remain in the dark for several more weeks im afraid.as a side note,im puzzled as to what,if anything ,is happening re young ai.there was a tweet from the company in july saying the app had been experiencing down time(my wording)whilst they were updating and redeveloping the app which they hoped to complete by september.so far as i can see,the app is no longer available on the app store.i may be wrong as im not very adept at finding these things, but it seems a bit odd.it may be that they are refocussing under our very own Deep on concentrating on the senoclock aspect in the corporate/commercial areas, rather than the domestic consumer market for young ai.which was probably always going to be a difficult sell (how many of us want to send in blood samples etc).just a sideshow to the main issues i know, but perhaps some light will be shed in the prospectus on this and the other issues,re FDA.

fair question, but with the growing importance of ESG considerations, i am hoping that whatever the cost, it will be one well spent.

https://www.bikeradar.com/news/silca-hot-wax-x/ bike radar article with just a little more detail.nice photo highlighting "nanene" on the tin.

https://www.cyclist.co.uk/news/11076/silca-hot-wax-x-chain-lube . silca
has today launched its new hot wax cycle chain lubricant, which incorporates graphene.courtesy of jointer on advfn.no idea of commercial value but the commentary refers to silca as the world leader. will be interesting see if we get an RNS tomorrow.

interesting RNS this morning.pleased to see SRC being very proactive in this area.helps to reinforce confidence in the quality of the management,imo.

https://www.thisismoney.co.uk/money/markets/article-11450161/M-S-makes-menswear-Xmas-push-Retailer-adding-clothing-ranges.html?ico=mol_desktop_money-newtab&molReferrerUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fmoney%2Findex.html&_ga=2.25362100.809709161.1668753239-758613370.1661027890 possible upturn in superdry's fortunes?

very much my thoughts Henry. let us hope our optimism is justified.

https://www.youtube.com/watch?v=FzqV-AxUgYwcouple of interesting new points which i haven't heard before.